Shared signatures and divergence in skin microbiomes of children with atopic dermatitis and their caregivers
Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Atopic dermatitis (AD) is a common chronic skin condition in children (15-20%) that can significantly impair their quality of life. As a result of its relapsing nature and enrichment of Staphylococcus aureus during flares, clinical management can include eradicating S aureus from the skin of children; however, this does not extend to their healthy caregivers, who are potential reservoirs.
OBJECTIVE: Our aim was to understand skin microbiome sharing and microbial features in children with AD and their healthy adult caregivers.
METHODS: We utilized whole-metagenome profiling at 4 body sites (volar forearm, antecubital fossae, cheeks, and lesions) in combination with sequencing of S aureus isolates to characterize a cohort of children with AD and their healthy caregivers (n = 30 families) compared to matched pairs from control households (n = 30 families).
RESULTS: Metagenomic analysis revealed distinct microbiome configurations in the nonlesional skin of AD children and their healthy caregivers versus controls, which were sufficient to accurately predict case-control status (area under the receiver operating characteristic curve > 0.8). These differences were accompanied by significant microbiome similarity between children and their caregivers, indicating that microbiome sharing may play a role in recurrent disease flares. Whole-genome comparisons with high-quality S aureus isolate genomes (n = 55) confirmed significant strain sharing between AD children and their caregivers and AD-specific enrichment of strains expressing enterotoxins Q and K/K2.
CONCLUSION: Our results highlight the distinctive skin microbiome features of healthy caregivers for children with AD and support their inclusion in strategies for the treatment of recurrent pediatric AD.
Errataetall: |
CommentIn: J Allergy Clin Immunol. 2022 Oct;150(4):793-795. - PMID 35931225 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:150 |
---|---|
Enthalten in: |
The Journal of allergy and clinical immunology - 150(2022), 4 vom: 25. Okt., Seite 894-908 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chia, Minghao [VerfasserIn] |
---|
Links: |
---|
Themen: |
Atopic dermatitis |
---|
Anmerkungen: |
Date Completed 10.10.2022 Date Revised 26.10.2022 published: Print-Electronic CommentIn: J Allergy Clin Immunol. 2022 Oct;150(4):793-795. - PMID 35931225 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jaci.2022.01.031 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM338484345 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM338484345 | ||
003 | DE-627 | ||
005 | 20231226000758.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaci.2022.01.031 |2 doi | |
028 | 5 | 2 | |a pubmed24n1128.xml |
035 | |a (DE-627)NLM338484345 | ||
035 | |a (NLM)35318044 | ||
035 | |a (PII)S0091-6749(22)00345-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Chia, Minghao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Shared signatures and divergence in skin microbiomes of children with atopic dermatitis and their caregivers |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.10.2022 | ||
500 | |a Date Revised 26.10.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: J Allergy Clin Immunol. 2022 Oct;150(4):793-795. - PMID 35931225 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved. | ||
520 | |a BACKGROUND: Atopic dermatitis (AD) is a common chronic skin condition in children (15-20%) that can significantly impair their quality of life. As a result of its relapsing nature and enrichment of Staphylococcus aureus during flares, clinical management can include eradicating S aureus from the skin of children; however, this does not extend to their healthy caregivers, who are potential reservoirs | ||
520 | |a OBJECTIVE: Our aim was to understand skin microbiome sharing and microbial features in children with AD and their healthy adult caregivers | ||
520 | |a METHODS: We utilized whole-metagenome profiling at 4 body sites (volar forearm, antecubital fossae, cheeks, and lesions) in combination with sequencing of S aureus isolates to characterize a cohort of children with AD and their healthy caregivers (n = 30 families) compared to matched pairs from control households (n = 30 families) | ||
520 | |a RESULTS: Metagenomic analysis revealed distinct microbiome configurations in the nonlesional skin of AD children and their healthy caregivers versus controls, which were sufficient to accurately predict case-control status (area under the receiver operating characteristic curve > 0.8). These differences were accompanied by significant microbiome similarity between children and their caregivers, indicating that microbiome sharing may play a role in recurrent disease flares. Whole-genome comparisons with high-quality S aureus isolate genomes (n = 55) confirmed significant strain sharing between AD children and their caregivers and AD-specific enrichment of strains expressing enterotoxins Q and K/K2 | ||
520 | |a CONCLUSION: Our results highlight the distinctive skin microbiome features of healthy caregivers for children with AD and support their inclusion in strategies for the treatment of recurrent pediatric AD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Atopic dermatitis | |
650 | 4 | |a Staphylococcus aureus | |
650 | 4 | |a caregivers | |
650 | 4 | |a household contact | |
650 | 4 | |a skin microbiome | |
650 | 7 | |a Enterotoxins |2 NLM | |
700 | 1 | |a Naim, Ahmad N M |e verfasserin |4 aut | |
700 | 1 | |a Tay, Angeline S L |e verfasserin |4 aut | |
700 | 1 | |a Lim, Karmun |e verfasserin |4 aut | |
700 | 1 | |a Chew, Kean Lee |e verfasserin |4 aut | |
700 | 1 | |a Yow, See Jie |e verfasserin |4 aut | |
700 | 1 | |a Chen, John |e verfasserin |4 aut | |
700 | 1 | |a Common, John E A |e verfasserin |4 aut | |
700 | 1 | |a Nagarajan, Niranjan |e verfasserin |4 aut | |
700 | 1 | |a Tham, Elizabeth Huiwen |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of allergy and clinical immunology |d 1971 |g 150(2022), 4 vom: 25. Okt., Seite 894-908 |w (DE-627)NLM000018449 |x 1097-6825 |7 nnns |
773 | 1 | 8 | |g volume:150 |g year:2022 |g number:4 |g day:25 |g month:10 |g pages:894-908 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaci.2022.01.031 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 150 |j 2022 |e 4 |b 25 |c 10 |h 894-908 |